Paolo Tarantino, Research Fellow Dana-Farber Cancer Institute and Harvard Medical Schoolpost, shared a post on X:
“Developing more effective therapies is critical. But just as important is to identify which pts may be cured with less chemo, an effort often only made possible thanks to philanthropy. Thanks to BCRF for supporting DAPHNe and for highlighting its results.”
Other articles about Chemotherapy on OncoDaily.